Evelyn W Ngugi1, Andrea A Kim, Raymond Nyoka, Lucy Ng'ang'a, Irene Mukui, Bernadette Ng'eno, George W Rutherford. 1. *Division of Global HIV/AIDS, Center for Global Health, US Centers for Disease Control and Prevention, Nairobi, Kenya; †National AIDS and Sexually Transmitted Infection (STI) Control Programme, Ministry of Health, Nairobi, Kenya; and ‡Global Health Sciences, University of California, San Francisco, San Francisco, CA.
Abstract
BACKGROUND: Prevention of unplanned pregnancies is a critical element in the prevention of mother-to-child transmission of HIV infection, but its potential has not been fully realized. We assessed the utilization of family planning (FP) and fertility desires among women of reproductive age by HIV status. METHODS: We selected a nationally representative sample of households using a stratified 2-stage cluster design and surveyed women aged 15-49 years. We administered questionnaires and examined predictors of current use of FP and desire for children among sexually active women with known HIV infection and women who were HIV uninfected. RESULTS: Of 3583 respondents, 68.2% were currently using FP, and 57.7% did not desire children in the future. Among women who did not desire children in the future, 70.9% reported that they were using FP, including 68.7% of women with known HIV infection and 71.0% of women who were HIV uninfected. Women with known HIV infection had similar odds of using FP as women with no HIV infection (odds ratio, 1.12; 95% confidence interval: 0.81 to 1.54). Women with no HIV infection had significantly higher adjusted odds of desiring future children (adjusted OR, 2.27; 95% confidence interval: 1.31 to 3.93) than women with known HIV infection. CONCLUSIONS: There is unmet need for FP for HIV-infected women, underscoring a gap in the national prevention of mother-to-child transmission of HIV strategy. Efforts to empower HIV-infected women to prevent unintended pregnancies should lead to expanded access to contraceptive methods and take into account women's reproductive intentions.
BACKGROUND: Prevention of unplanned pregnancies is a critical element in the prevention of mother-to-child transmission of HIV infection, but its potential has not been fully realized. We assessed the utilization of family planning (FP) and fertility desires among women of reproductive age by HIV status. METHODS: We selected a nationally representative sample of households using a stratified 2-stage cluster design and surveyed women aged 15-49 years. We administered questionnaires and examined predictors of current use of FP and desire for children among sexually active women with known HIV infection and women who were HIV uninfected. RESULTS: Of 3583 respondents, 68.2% were currently using FP, and 57.7% did not desire children in the future. Among women who did not desire children in the future, 70.9% reported that they were using FP, including 68.7% of women with known HIV infection and 71.0% of women who were HIV uninfected. Women with known HIV infection had similar odds of using FP as women with no HIV infection (odds ratio, 1.12; 95% confidence interval: 0.81 to 1.54). Women with no HIV infection had significantly higher adjusted odds of desiring future children (adjusted OR, 2.27; 95% confidence interval: 1.31 to 3.93) than women with known HIV infection. CONCLUSIONS: There is unmet need for FP for HIV-infectedwomen, underscoring a gap in the national prevention of mother-to-child transmission of HIV strategy. Efforts to empower HIV-infectedwomen to prevent unintended pregnancies should lead to expanded access to contraceptive methods and take into account women's reproductive intentions.
Authors: Mary Lou Lindegren; Caitlin E Kennedy; Deborah Bain-Brickley; Hana Azman; Andreea A Creanga; Lisa M Butler; Alicen B Spaulding; Tara Horvath; Gail E Kennedy Journal: Cochrane Database Syst Rev Date: 2012-09-12
Authors: Wanjiru Waruiru; Andrea A Kim; Davies O Kimanga; James Ng'ang'a; Sandra Schwarcz; Lucy Kimondo; Anne Ng'ang'a; Mamo Umuro; Mary Mwangi; James K Ojwang'; William K Maina Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: Abhijeet Anand; Ray W Shiraishi; Rebecca E Bunnell; Krista Jacobs; Nadia Solehdin; Abu S Abdul-Quader; Lawrence H Marum; James N Muttunga; Kelita Kamoto; John M Aberle-Grasse; Theresa Diaz Journal: AIDS Date: 2009-07-31 Impact factor: 4.177
Authors: Elizabeth K Harrington; Sara J Newmann; Maricianah Onono; Katie D Schwartz; Elizabeth A Bukusi; Craig R Cohen; Daniel Grossman Journal: Infect Dis Obstet Gynecol Date: 2012-07-12
Authors: Kate S Wilson; George Wanje; Linnet Masese; Jane M Simoni; Juma Shafi; Lucy Adala; Julie Overbaugh; Walter Jaoko; Barbra A Richardson; Raymond S McClelland Journal: J Acquir Immune Defic Syndr Date: 2018-07-01 Impact factor: 3.731
Authors: William K Maina; Andrea A Kim; George W Rutherford; Malayah Harper; Boniface O K'Oyugi; Shahnaaz Sharif; George Kichamu; Nicholas M Muraguri; Willis Akhwale; Kevin M De Cock Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: Joanna Paula Cordero; Petrus S Steyn; Peter Gichangi; Yolandie Kriel; Cecilia Milford; Margarate Munakampe; Irene Njau; Theresa Nkole; Adam Silumbwe; Jennifer Smit; James Kiarie Journal: Afr J Reprod Health Date: 2019-09
Authors: Erica M Lokken; George Wanje; Barbra A Richardson; Esther Mutunga; Kate S Wilson; Walter Jaoko; John Kinuthia; Raymond Scott McClelland Journal: J Acquir Immune Defic Syndr Date: 2020-09-01 Impact factor: 3.771
Authors: Victor Akelo; Eleanor McLellan-Lemal; Lauren Toledo; Sonali Girde; Craig B Borkowf; Laura Ward; Kenneth Ondenge; Richard Ndivo; Shirley L Lecher; Lisa A Mills; Timothy K Thomas Journal: PLoS One Date: 2015-06-29 Impact factor: 3.240
Authors: Brenda Asiimwe-Kateera; Nienke Veldhuijzen; Jean Paul Balinda; John Rusine; Sally Eagle; Joseph Vyankandondera; Julie Mugabekazi; Pascale Ondoa; Kimberly Boer; Anita Asiimwe; Joep Lange; Peter Reiss; Janneke van de Wijgert Journal: AIDS Res Treat Date: 2015-07-16